Basic & Clinical Medicine ›› 2023, Vol. 43 ›› Issue (9): 1453-1456.doi: 10.16352/j.issn.1001-6325.2023.09.1453
• Mini Reviews • Previous Articles Next Articles
YANG Yaqian, PAN Yanfang*, QU Mengyang, FANG Yan, YING Xiaoping, ZHANG Meiqian, WEI Jing
Received:
2022-10-10
Revised:
2023-02-27
Online:
2023-09-05
Published:
2023-09-01
Contact:
*panyanfang2000@163.com
CLC Number:
YANG Yaqian, PAN Yanfang, QU Mengyang, FANG Yan, YING Xiaoping, ZHANG Meiqian, WEI Jing. Progress of research on the role of exosomes in the occurrence and development of liver precancerous lesions[J]. Basic & Clinical Medicine, 2023, 43(9): 1453-1456.
[1] | Ren X, Dong Y, Duan M, et al. Abnormal expression of HNRNPA3 in multistep hepatocarcinogenesis[J]. Oncol Lett, 2021, 21:46. doi: 10.3892/ol.2020.12307. |
[2] | Fateen W, Johnson PJ, Wood HM, et al. Characterisation of dysplastic liver nodules using low-pass DNA sequencing and detection of chromosome arm-level abnormalities in blood-derived cell-free DNA[J]. J Pathol, 2021, 255:30-40. |
[3] | De Nunzio V, Carrieri L, Scavo MP, et al. Plasma-derived exosomes from NAFLD patients modulate the cannabinoid receptors′ expression in cultured HepaRG cells[J]. Int J Mol Sci, 2023, 24:1739. doi: 10.3390/ijms24021739. |
[4] | Tong L, Yan C, Wang M, et al. Prognostic value of serum exosomal AHCY expression in hepatitis B-induced liver cirrhosis[J]. Front Med (Lausanne), 2021, 8:777452. doi: 10.3389/fmed.2021.777452. |
[5] | Sanchez JI, Jiao J, Kwan SY, et al. Lipidomic profiles of plasma exosomes identify candidate biomarkers for early detection of hepatocellular carcinoma in patients with cirrhosis[J]. Cancer Prev Res (Phila), 2021, 14:955-962. |
[6] | Wu B, Feng J, Guo J, et al. ADSCs-derived exosomes ameliorate hepatic fibrosis by suppressing stellate cell activation and remodeling hepatocellular glutamine synthetase-mediated glutamine and ammonia homeostasis[J]. Stem Cell Res Ther, 2022, 13:494. doi: 10.1186/s13287-022-03049-x. |
[7] | Koksal AR, Thevenot P, Aydin Y, et al. Impaired autophagy response in hepatocellular carcinomas enriches glypican-3 in exosomes, not in the microvesicles[J]. J Hepatocell Carcinoma, 2022, 9:959-972. |
[8] | Aydin Y, Koksal AR, Thevenot P, et al. Experimental validation of novel glypican 3 exosomes for the detection of hepatocellular carcinoma in liver cirrhosis[J]. J Hepatocell Carcinoma, 2021, 8:1579-1596. |
[9] | Lee J, Jeong I, Kim OK. Liver-derived exosomes induce inflammation and lipogenesis in mice fed high-energy diets[J]. Nutrients, 2022, 14:5124. doi: 10.3390/nu14235124. |
[10] | Zhang Z, Shang J, Yang Q, et al. Exosomes derived from human adipose mesenchymal stem cells ameliorate hepatic fibrosis by inhibiting PI3K/Akt/mTOR pathway and remodeling choline metabolism[J]. J Nanobiotechnology, 2023, 21:29. doi: 10.1186/s12951-023-01788-4. |
[11] | Chen L, Huang Y, Duan Z, et al. Exosomal miR-500 derived from lipopolysaccharide-treated macrophage accele-rates liver fibrosis by suppressing MFN2[J]. Front Cell Dev Biol, 2021, 9:716209. doi: 10.3389/fcell.2021.716209. |
[12] | Kim HY, Min HK, Song HW, et al. Delivery of human natural killer cell-derived exosomes for liver cancer therapy: an in vivo study in subcutaneous and orthotopic animal models[J]. Drug Deliv, 2022, 29:2897-2911. |
[13] | Li Z, Zhao P, Zhang Y, et al. Exosome-based ldlr gene therapy for familial hypercholesterolemia in a mouse model[J]. Theranostics, 2021, 11:2953-2965. |
[14] | Zhang Q, Qu Y, Zhang Q, et al. Exosomes derived from hepatitis B virus-infected hepatocytes promote liver fibrosis via miR-222/TFRC axis[J]. Cell Biol Toxicol, 2022,: 1-15. |
[15] | Zhang Y, Zhangdi H, Nie X, et al. Exosomes derived from BMMSCs mitigate the hepatic fibrosis via anti-pyroptosis pathway in a cirrhosis model[J]. Cells, 2022, 11:4004. doi: 10.3390/cells11244004. |
[16] | Hasanin AH, Matboli M, Seleem HS. Hesperidin suppressed hepatic precancerous lesions via modulation of exophagy in rats[J]. J Cell Biochem, 2020, 121: 1295-1306. |
[17] | Dai X, Chen C, Yang Q, et al. Exosomal circRNA_100284 from arsenite-transformed cells, via microRNA-217 regulation of EZH2, is involved in the malignant transformation of human hepatic cells by accelerating the cell cycle and promoting cell proliferation[J]. Cell Death Dis, 2018, 9: 454-467. |
[18] | Fründt T, Krause L, Hussey E, et al. Diagnostic and prognostic value of miR-16, miR-146a, miR-192 and miR-221 in exosomes of hepatocellular carcinoma and liver cirrhosis patients[J]. Cancers (Basel), 2021, 13: 2484.doi:10.3390/cancers13102484. |
[19] | Lin Y, Dong MQ, Liu ZM, et al. A strategy of vascular-targeted therapy for liver fibrosis[J]. Hepatology, 2022, 76:660-675. |
[20] | Witek RP, Yang L, Liu R, et al. Liver cell-derived microparticles activate hedgehog signaling and alter gene expression in hepatic endothelial cells[J]. Gastroenterology, 2009, 136:320-330. |
[21] | Wei H, Xu Z, Chen L, et al. Long non-coding RNA PAARH promotes hepatocellular carcinoma progression and angiogenesis via upregulating HOTTIP and activating HIF-1α/VEGF signaling[J]. Cell Death Dis, 2022, 13:102. doi: 10.1038/s41419-022-04505-5. |
[22] | Han L, Lin X, Yan Q, et al. PBLD inhibits angiogenesis via impeding VEGF/VEGFR2-mediated microenvironmental cross-talk between HCC cells and endothelial cells[J]. Oncogene, 2022, 41:1851-1865. |
[23] | Chen QL, Xie CF, Feng KL, et al. microRNAs carried by exosomes promote epithelial-mesenchymal transition and metastasis of liver cancer cells[J]. Am J Transl Res, 2020, 12:6811-6826. |
[24] | Xie CF, Feng KL, Wang JN, et al. Jianpi huayu decoction inhibits the epithelial-mesenchymal transition of hepatocellular carcinoma cells by suppressing exosomal miR-23a-3p/Smad signaling[J]. J Ethnopharmacol, 2022, 294:115360. doi: 10.1016/j.jep.2022.115360. |
[25] | Benbow JH, Marrero E, McGee RM, et al. Hepatic stellate cell-derived exosomes modulate macrophage inflammatory response[J]. Exp Cell Res, 2021, 405: 112663-112672. |
[1] | YU Manshu, ZHAO Xiaomin, QIU Mingyue, LIU Chunran, NA Risu. Advances in the treatment of dental stem cells for Parkinson′s disease [J]. Basic & Clinical Medicine, 2024, 44(9): 1298-1302. |
[2] | ZHAO Junli, ZHU Junjun, ZHAN Qiunan, LIU Miao. Bone marrow mesenchymal stem cell-derived exosome inhibits high glucose-induced EMT of peritoneal mesothelial cells [J]. Basic & Clinical Medicine, 2024, 44(8): 1149-1156. |
[3] | GAO Lu, CAI Menghua, XU Yi, HE Wei, CHEN Hui, ZHANG Jianmin. Purification and in vitro functional validation of exosomes from 293T cells with over-expressed membrane-localized IL-3 [J]. Basic & Clinical Medicine, 2024, 44(7): 947-953. |
[4] | CHEN Xiaotian, CHEN Chong, LUO Yunping. Impact of MAFB on polarization and function of tumor associated macrophages [J]. Basic & Clinical Medicine, 2024, 44(7): 965-973. |
[5] | SONG Boyuan, WU Xueli, LI Xueyuan, WANG Lisha, CHEN Yang. Dynamic transcriptomic analysis of macrophages infected with Salmonella typhimurium [J]. Basic & Clinical Medicine, 2024, 44(6): 779-785. |
[6] | ZHANG Diya, LI Yunfan, GUO Hongjiang, QIU Jiaxing, WANG Yucheng, JU Rui, GUO Lei. Glioma conditioned medium promotes glycolysis and phenotypic transformation in macrophages [J]. Basic & Clinical Medicine, 2024, 44(5): 599-605. |
[7] | ZHAO Dong, ZHA Shiqian, WANG Yixuan, PAN Zhou, YU Wenzhen, HU Ke. Macrophage-to-myofibroblast transition promotes pulmonary fibrosis occurred in LPS-induced acute lung injury of mouse models [J]. Basic & Clinical Medicine, 2024, 44(3): 281-287. |
[8] | YU Hanqiao, LI Chao, YU Yubin, FENG Lina, SHENG Xiaosheng, YE Xiaoxia, WANG Linyan. Inhibition of triggering receptor expressed on myeloid cells-1(TREM-1) attenuates chronic intermittent hypoxia-induced atherosclerosis in mouse models [J]. Basic & Clinical Medicine, 2024, 44(3): 368-373. |
[9] | CHEN Weiwei, LIAO Huang, SHI Zhenhong, LUO Ying. FHL2 regulates THP-1 macrophage foaming through NF-κB signaling pathway [J]. Basic & Clinical Medicine, 2024, 44(2): 204-209. |
[10] | SUN Lijie, HAO Dandan. Progress of researches on inducing hepatic stellate cell ferroptosis for treatment of liver fibrosis [J]. Basic & Clinical Medicine, 2024, 44(1): 108-113. |
[11] | CHEN Xin, CHEN Jun, XU Xing, WANG Xu. Histone demethylase inhibitor GSK-J4 reduces body weight in high-fat diet-induced obese mice [J]. Basic & Clinical Medicine, 2023, 43(9): 1353-1358. |
[12] | YAN Chenhong, JIN Er. Progress of exosomal PD-L1 in diagnosis and treatment of non-small cell lung cancer [J]. Basic & Clinical Medicine, 2023, 43(9): 1457-1461. |
[13] | FANG Lu, LIU Ruiqi, LIANG Peng, CEN Ying. Progress on the role of exosomal miRNAs in organ fibrosis [J]. Basic & Clinical Medicine, 2023, 43(9): 1472-1476. |
[14] | CHEN Xingxing, SAI Yipa, HU Xiaoxia, WANG Sanping, LUO Xuan, LIU Jing. Neuroprotective effects of exosomes derived from human umbilical cord mesenchymal stem cells in cerebral palsy mice [J]. Basic & Clinical Medicine, 2023, 43(8): 1201-1207. |
[15] | ZHANG Baorui, MA Chunxiao, QIN Lijie. STAT1-induced LINC00987 regulates miR-223-3p/FZD4 and promotes M2-type polarization of human glioblastoma-associated macrophages [J]. Basic & Clinical Medicine, 2023, 43(7): 1060-1068. |
Viewed | ||||||
Full text 82
|
|
|||||
Abstract |
|
|||||